Kidney stones are one of the most common urological diseases worldwide and represent a growing burden on healthcare systems. Traditional diagnostic procedures and therapeutic approaches, from imaging and drug-based stone dissolution to invasive surgical methods, are fraught with limitations. Nanomedicine opens up new perspectives here: Nanomaterials enable more precise early detection, improve imaging, have antioxidant and antibacterial effects, transport drugs in a more targeted manner and can even control biofilm-associated infections. The following article presents the latest advances in this field and discusses the clinical relevance for nephrologists.
You May Also Like
- Hereditary Transthyretin Amyloidosis with Polyneuropathy
New Treatment Options for ATTRv-PN
- Type 1 Diabetes: A New Disease-Modifying Treatment Approach
Slowing the loss of β-cell function and delaying the progression of the disease
- Liver Cancer
Artificial Intelligence in Precision Oncology—Opportunities and Challenges
- Acute nonspecific back pain
Implementing a biopsychosocial approach
- Neuropathic Pain
Evidence-Based Neuromodulation Based on Clinical Trials and Real-World Data
- Psychedelic-assisted therapy
Current status of PAT
- Fibromyalgia Syndrome
Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity
- Juvenile Idiopathic Arthritis